Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 10 (RPL7AP10)

Target: RPL7AP10
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L7a pseudogene 10 (RPL7AP10) is one of numerous processed pseudogenes derived from the RPL7A gene, which encodes a component of the large ribosomal 60S subunit[1][7]. Pseudogenes such as RPL7AP10 result from genetic duplication or retrotransposition, but lack the proper regulatory elements or coding sequence to create a functional protein. As such, RPL7AP10 does not have an active biological function, is not considered a therapeutic target, and does not contribute to disease pathology or serve as a biomarker.

Other names: RPL7AP3RPL7AP68RPL7A_31_1637rpL7aribosomal protein L7a pseudogene 3ribosomal protein L7a pseudogene 68RPL7AP10

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 10 (RPL7AP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 10 (RPL7AP10).

Explore the full profile